IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Preferred Stock Liabilities (2018 - 2019)

Updated

IRulya Therapeutics (IRLA) posted Preferred Stock Liabilities of $104.14 million for Q1 2019, up 506.2% from $17.18 million a year earlier and up 0.1% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

At the end of FY2018, IRulya Therapeutics' Preferred Stock Liabilities came in at $104.05 million.

  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $104.05 million (Q4 2018), $103.95 million (Q3 2018) and $103.89 million (Q2 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 104.14 Mn
Dec 31, 2018 104.05 Mn
Sep 30, 2018 103.95 Mn
Jun 30, 2018 103.89 Mn
Mar 31, 2018 17.18 Mn
API Access

IRulya Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=IRLA&period=max&api_key=YOUR_API_KEY